| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/17/2003 | US20030134318 Methods of using randomized libraries of zinc finger proteins for the identification of gene function |
| 07/17/2003 | US20030134310 Cellular kinase targets and inhibitors, and methods for their use |
| 07/17/2003 | US20030134306 Human and murine cytokine polypeptides |
| 07/17/2003 | US20030134284 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/17/2003 | US20030134270 Rapid method of selecting cells for gene disruption by homologous recombination |
| 07/17/2003 | US20030134266 Methods of screening for compounds that modulate blood vessel formation |
| 07/17/2003 | US20030134263 Controlling gene expression; transfection of cell |
| 07/17/2003 | US20030133938 Antibody-avidin fusion proteins as cytotoxic drugs |
| 07/17/2003 | US20030133919 An immunogene therapy for treating diseases associated with excessive interleukin-18 induced immunoreaction; administering a transfected cells, preventing autoimmune and allergic disease |
| 07/17/2003 | US20030133918 Cell culturing, expressing a protein through the guanine nucleotide biosynthesis pathway, treating wound repair; wound healing agents |
| 07/17/2003 | US20030133917 Therapeutic treatment of human tumors, cancers and infected cells; a viral vector containing a DNA insert as antitumor agents, anticarcinogenic agents, viricides, fungicides, bactericides |
| 07/17/2003 | US20030133915 Appling hydrostatic pressure |
| 07/17/2003 | US20030133914 Method for suppressing immune system response to transplanted tissue or cells |
| 07/17/2003 | US20030133913 Producing chemokine receptors, inducing antigen by dendritic cells in vitro, for therapeutic or prophylactic purposes |
| 07/17/2003 | US20030133912 Receptor-targeted adenoviral vectors |
| 07/17/2003 | US20030131532 Floral packaging material having great masters prints thereon |
| 07/17/2003 | CA2854024A1 Corn plants with improved quality grain traits |
| 07/17/2003 | CA2795814A1 Proteases producing an altered immunogenic response and methods of making and using the same |
| 07/17/2003 | CA2767061A1 Specific binding agents of human angiopoietin-2 |
| 07/17/2003 | CA2473226A1 Diagnostics and vaccines for mycrobacterium paratuberculosis infections |
| 07/17/2003 | CA2472647A1 Mammal prolactin variants |
| 07/17/2003 | CA2472383A1 Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor |
| 07/17/2003 | CA2472328A1 Fusion proteins |
| 07/17/2003 | CA2472282A1 Gene products differentially expressed in cancerous breast cells and their methods of use |
| 07/17/2003 | CA2472206A1 Proteases producing an altered immunogenic response and methods of making and using the same |
| 07/17/2003 | CA2472180A1 Hair follicle growth |
| 07/17/2003 | CA2472118A1 Pak5-related compositions and methods |
| 07/17/2003 | CA2472111A1 Human mast cell-expressed membrane proteins |
| 07/17/2003 | CA2472049A1 Dominant negative proteins and methods thereof |
| 07/17/2003 | CA2471972A1 Proteases producing an altered immunological response and methods of making and using the same |
| 07/17/2003 | CA2471874A1 Compositions and methods for hydroxylating epothilones |
| 07/17/2003 | CA2471868A1 Methods of generating multispecific, multivalent agents from vh and vl domains |
| 07/17/2003 | CA2471840A1 Novel compositions and methods for cancer |
| 07/17/2003 | CA2471827A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
| 07/17/2003 | CA2471551A1 Methods to engineer mammalian-type carbohydrate structures |
| 07/17/2003 | CA2471431A1 Compositions and methods for the diagnosis and treatment of tumor |
| 07/17/2003 | CA2470012A1 Novel proteins and nucleic acids encoding same |
| 07/17/2003 | CA2469052A1 Transdifferentiation of pancreatic acinar cells |
| 07/17/2003 | CA2467084A1 Mutant chromophores/fluorophores and methods for making and using the same |
| 07/17/2003 | CA2467083A1 Viral capsid assembly intermediates |
| 07/17/2003 | CA2439471A1 Promoters of the growth and/or differentiation of hematopoietic stem cells and/or hematopoietic progenitors |
| 07/16/2003 | EP1327685A1 Bzip transcripiton factors that controls expression of the storage protein in the rice plant |
| 07/16/2003 | EP1327683A2 Human papilloma virus inhibition by a hairpin ribozyme |
| 07/16/2003 | EP1327678A1 Method and apparatus for peeling cells from vital tissue |
| 07/16/2003 | EP1327638A1 Novel dendritic cell wall membrane and use thereof |
| 07/16/2003 | EP1327452A2 Pharmaceutical compositions based on anticholinergically effective compounds and beta-mimetics |
| 07/16/2003 | EP1327145A2 Cells having a spectral signature, and methods of preparation and use thereof |
| 07/16/2003 | EP1327003A2 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products |
| 07/16/2003 | EP1326998A2 Cd38 modulated chemotaxis |
| 07/16/2003 | EP1326995A2 Method for synthesising peptides, peptide mimetics and proteins |
| 07/16/2003 | EP1326990A2 Packaging of positive-strand rna virus replicon particles |
| 07/16/2003 | EP1326987A1 Chimeric cytoplasmic signalling molecules derived from cd137 |
| 07/16/2003 | EP1326986A2 Regulation of human sphingosine kinase-like protein |
| 07/16/2003 | EP1326984A2 Cytochrome p450 monooxygenases consisting of thermophilic bacteria |
| 07/16/2003 | EP1326983A2 Gene cluster for ramoplanin biosynthesis |
| 07/16/2003 | EP1326978A2 Hematopoietin receptors hpr1 and hpr2 |
| 07/16/2003 | EP1326976A1 Mfq-114, a human ajuba like protein |
| 07/16/2003 | EP1326972A2 Transporters and ion channels |
| 07/16/2003 | EP1326971A2 Proteins and nucleic acids encoding same |
| 07/16/2003 | EP1326968A1 Non-disruptive three-dimensional culture and harvest system for anchorage-dependent cells |
| 07/16/2003 | EP1326967A2 Novel aggrecanase molecules |
| 07/16/2003 | EP1326962A2 Method for producing vital, biological substitute tissue in vitro using cell cultures and a support |
| 07/16/2003 | EP1326961A2 Compositions and methods for inducing specific cytolytic t cell responses |
| 07/16/2003 | EP1326957A2 Method for the prevention or reduction of haze in beverages |
| 07/16/2003 | EP1326897A2 Humanized anti-lt-beta-r antibodies |
| 07/16/2003 | EP1326895A1 Monoclonal antibodies directed against hepatitis b viruses |
| 07/16/2003 | EP1326894A2 Novel tumor-associated marker |
| 07/16/2003 | EP1326891A1 Gene encoding a human g-protein coupled receptor and its use |
| 07/16/2003 | EP1326890A2 Shrimp alkaline phosphatase |
| 07/16/2003 | EP1326882A2 Enterokinase cleavage sequences and their use |
| 07/16/2003 | EP1326879A2 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |
| 07/16/2003 | EP1326674A2 Microstructures for delivering a composition cutaneously to skin |
| 07/16/2003 | EP1326673A2 Microstructures for treating and conditioning skin |
| 07/16/2003 | EP1326654A2 Methods and compositions for tissue regeneration |
| 07/16/2003 | EP1326645A1 Complexes for transferring nucleic acids into cells |
| 07/16/2003 | EP1326629A2 Methods and compositions for promoting the maturation of monocytes |
| 07/16/2003 | EP1326628A2 Chemokine mutants in the treatment of multiple sclerosis |
| 07/16/2003 | EP1326625A1 Immunogenic composition of hepatitis c and methods of use thereof |
| 07/16/2003 | EP1326597A2 Methods for modulating bladder function |
| 07/16/2003 | EP1079772A4 Corporal tissue penile reconstruction |
| 07/16/2003 | EP1025231B1 Robo: a family of polypeptides and nucleic acids involved in nerve cell guidance |
| 07/16/2003 | EP0975354A4 Ligand/lytic peptide compositions and methods of use |
| 07/16/2003 | EP0801658B1 Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples |
| 07/16/2003 | CN1430673A Cestrum yellow leaf curling virus promoters |
| 07/16/2003 | CN1430670A Thermostable reverse transcriptases and uses thereof |
| 07/16/2003 | CN1430626A Sheep lice Bobicola ovis allergen treatment |
| 07/16/2003 | CN1429904A Method for gene conversion of corn |
| 07/16/2003 | CN1429845A Mouse antichloromycetin monoclonal antibody and its use |
| 07/16/2003 | CN1429624A Lung cancer transgene vaccine and its preparation method |
| 07/16/2003 | CN1429561A Non-operation method of constructing human/goat mosaic |
| 07/16/2003 | CN1114694C Method and material for conferring disease resistance in plants |
| 07/16/2003 | CN1114692C Plastid transformation in arabidopsis thaliana |
| 07/16/2003 | CN1114619C Preparation method of liver cancer murine monoclone antibody of mouse hybridoma strain Hepama-1 secretory |
| 07/15/2003 | US6593514 Method for the production of calendic acid, a fatty acid containing delta-8,10,12 conjugated double bonds and related fatty acids having a modification at the delta-9 position |
| 07/15/2003 | US6593463 Malarial merozite surface protein (MSP); modified nucleic acid sequence; AT content has been reduced by replacing codons with mammary gland preferred codons; useful in development of a vaccine against malaria |
| 07/15/2003 | US6593456 Polypeptide for use in the treatment rheumatoid arthritis |
| 07/15/2003 | US6593309 Contacting a sample containing sperm with a solution comprising a polysaccharide containing arabinose, galactose and/or hexuronic acid (PCAGH) to form a mixture, wherein the PCAGH is not arabinogalactan; separating sperm from the sample |
| 07/15/2003 | US6593140 Animal cell culture |
| 07/15/2003 | US6593139 Initiation of full mammalian oocyte activation by multiple sperm components |
| 07/15/2003 | US6593138 Cryogenic broth for use in the preservation of cells in freezing temperatures |